Eiger BioPharma (EIGR) PT Lowered to $22 at Wedbush, Following Announcement Of FDA Approval
Tweet Send to a Friend
Wedbush analyst Liana Moussatos lowered ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
